UNIVASC Drug Patent Profile
✉ Email this page to a colleague
When do Univasc patents expire, and what generic alternatives are available?
Univasc is a drug marketed by Ucb Inc and is included in one NDA.
The generic ingredient in UNIVASC is moexipril hydrochloride. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the moexipril hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Univasc
A generic version of UNIVASC was approved as moexipril hydrochloride by TEVA on May 8th, 2003.
Summary for UNIVASC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 2 |
Patent Applications: | 4,970 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in UNIVASC? | UNIVASC excipients list |
DailyMed Link: | UNIVASC at DailyMed |
Recent Clinical Trials for UNIVASC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Nebraska | Phase 4 |
Paddock Laboratories, Inc. | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for UNIVASC
US Patents and Regulatory Information for UNIVASC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-001 | Apr 19, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-002 | Apr 19, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for UNIVASC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-002 | Apr 19, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-001 | Apr 19, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-002 | Apr 19, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for UNIVASC
See the table below for patents covering UNIVASC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 52665 | SUBSTITUTED ACYL DERIVATIVES OF 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS,SALTS THEREOF,PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVE OR SALTS,AND THE PRODUCTION OF SAME | ⤷ Try a Trial |
Canada | 1300510 | COMPOSITION STABILISEE CONTENANT UNE ENZYNE CONVERTISSANT L'ANGIOTENSINE (STABILIZED COMPOSITION CONTAINING ANGIOTENSIN CONVERTING ENZYME) | ⤷ Try a Trial |
Australia | 5299186 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for UNIVASC
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0096157 | SPC/GB95/011 | United Kingdom | ⤷ Try a Trial | SPC/GB95/011:, EXPIRES: 20060930 |
0049605 | SPC/GB93/099 | United Kingdom | ⤷ Try a Trial | SPC/GB93/099, EXPIRES: 20040413 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |